Endometrial carcinosarcoma
G Bogani, I Ray-Coquard, N Concin… - International Journal of …, 2023 - ijgc.bmj.com
Endometrial carcinosarcoma is a rare and aggressive high-grade endometrial carcinoma
with secondary sarcomatous trans-differentiation (conversion theory). The clinical …
with secondary sarcomatous trans-differentiation (conversion theory). The clinical …
Comparing the survival rates of patients with stage IIIC endometrial cancer undergoing sandwich therapy to those undergoing sequential chemotherapy and …
MM Zhang, YK Chen, L Shi, J Ma, JD Jia… - Clinical and Translational …, 2024 - Springer
Background The use of additional treatment after surgery for stage IIIC endometrial cancer
(EC) according to the Federation of Gynecology and Obstetrics (FIGO) is still a topic of …
(EC) according to the Federation of Gynecology and Obstetrics (FIGO) is still a topic of …
Prognostic model for the exemption of adjuvant chemotherapy in stage IIIC endometrial cancer patients
XL Yang, FL Yang, LN Kou, DJ Wu, C Xie - Frontiers in Endocrinology, 2022 - frontiersin.org
Background This study aimed to develop a nomogram to predict the survival for stage IIIC
endometrial cancer (EC) patients with adjuvant radiotherapy (ART) alone and personalize …
endometrial cancer (EC) patients with adjuvant radiotherapy (ART) alone and personalize …
A population-based risk scoring system to individualize adjuvant treatment for stage IIIC endometrial cancer patients after surgery
XL Yang, YE Zhang, LN Kou, FL Yang… - European Journal of …, 2023 - Elsevier
Background To develop a risk scoring system to tailor the adjuvant treatment for stage IIIC
EC patients after surgery. Methods Data source was from the Surveillance, Epidemiology …
EC patients after surgery. Methods Data source was from the Surveillance, Epidemiology …
Treatment Outcomes and Toxicity Profiles with PORTEC-3 Trial Regimen in South Asian Cohort of High-Risk Endometrial Cancer Patients: A Single-Center …
P Verma, R Rajan, A Sasidharan… - South Asian Journal …, 2024 - thieme-connect.com
Objectives Adjuvant chemoradiation followed by chemotherapy is the current standard of
care in high-risk endometrial cancer after the PORTEC-3 trial. There is a lack of data on this …
care in high-risk endometrial cancer after the PORTEC-3 trial. There is a lack of data on this …
Addition of External Beam Radiation Therapy to Adjuvant Chemotherapy for Patients With Stage IIIC Uterine Endometrioid Carcinoma: Utilization and Outcomes
Objectives: Evaluate whether the addition of external beam radiation (EBRT) to adjuvant
chemotherapy with or without vaginal brachytherapy is associated with better survival for …
chemotherapy with or without vaginal brachytherapy is associated with better survival for …
[引用][C] What's in your “lunchbox”? Sandwich versus sequential chemotherapy and irradiation for advanced endometrial cancer
G Glaser, J Weroha - Gynecologic oncology, 2024 - gynecologiconcology-online.net
When physicians who give adjuvant therapy for advanced endometrial cancer are surveyed
regarding their treatment approaches, opinions vary widely. In a 2020 Society of …
regarding their treatment approaches, opinions vary widely. In a 2020 Society of …